Beauty Health Business Summary

The Beauty Health Company (SKIN) operates a high-margin "razor and blade" business model centered on its flagship Hydrafacial platform, generating revenue through two primary segments: Delivery Systems (Devices) and Consumables. The company sells advanced aesthetic delivery systems, including the Syndeo and SkinStylus microneedling devices, which establish an installed base for recurring sales of single-use tips, specialized serums, and boosters. As of early 2026, consumables represent approximately 71% of total net sales, providing a resilient, recurring revenue stream that mitigates the volatility of capital equipment cycles. Beauty Health competes directly with medical aesthetic and equipment firms such as CeriBell, MiMedx Group, and Nu Skin Enterprises, maintaining a dominant market position as the category creator in hydradermabrasion with a global footprint of over 35,000 active delivery systems. The company’s foundational technology was co-founded in 1997 by William "Bill" Cohen and Roger Ignon under Edge Systems, eventually transitioning to its current public structure via a 2021 business combination led by Executive Chairman Brent Saunders, the former CEO of Allergan. The current leadership team is headed by President and CEO Pedro Malha, who assumed the role in October 2025 after serving as a Worldwide Division President at Abbott Laboratories. The executive suite includes CFO Michael Monahan, formerly of Casper and Nutrisystem, and Sheri Lewis, who serves as Chief Operations, Quality and Technology Officer. The company is overseen by a board of directors that includes industry veterans like Philippe Schaison, former President of Allergan Aesthetics, and is backed by major institutional investors such as Fidelity (FMR LLC), BlackRock, and Vanguard.